You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昊海生物科技(06826.HK)附屬斥2,500萬人幣增資亨泰視覺
阿思達克 03-22 09:20
昊海生物科技(06826.HK)公布,全資子公司昊海發展與金亨泰簽署《投資協議》,以1,500萬元人民幣(下同)購入金亨泰持有的亨泰視覺10%股權,同時以1,000萬元增資認購亨泰視覺。完成後,昊海發展持有亨泰視覺55%股權。

另外,昊海控股與亨泰光學及亨泰視覺簽署《獨家經銷合同》,授予亨泰視覺高端角膜塑形用硬性透氣接觸鏡產品於中國內地經銷,為期10年,並持續授予亨泰視覺兒童近視管理及控制的光學鏡片「貝視得」於中國大陸地區的獨家經銷權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account